IVDR Article 14: Distributor Obligations in the EU Supply Chain

1. Key takeaways

A distributor is the economic operator that makes devices already placed on the EU market available further along the supply chain. Article 14 requires it to verify, before making a device available, that the device bears the CE mark and is accompanied by the EU Declaration of Conformity and instructions for use, and to confirm that the manufacturer and, where applicable, the importer and the authorised representative have completed their identification obligations. Where the verification shows non-conformity, the device may not be made available, and the relevant parties must be informed. Distributors must also store and transport devices under the conditions specified by the manufacturer and cooperate in traceability and corrective actions. In day-to-day terms, the distributor carries a documentation-chain plus identification-chain duty, a storage and transport duty with real technical content, and — through Article 16 — a latent risk of assuming full manufacturer obligations if it steps beyond its role.

2. Legal basis

3. Expert insights

Insight 1: The distributor verification is a double check of the documentation chain and the identification chain.

Article 14 requires verification of the CE mark, the EU Declaration of Conformity and the instructions for use, together with the identification information of the manufacturer and, where applicable, the importer. Compared with the importer, the distributor does not face the third-country source directly, but it carries the same duty to stop making a device available and to notify the relevant parties once a non-conformity is identified. The practical consequence is that every distributor needs a documented intake procedure: without records of what was checked at goods-in, a distributor cannot demonstrate that the verification duty was exercised at all, and in an enforcement scenario the absence of records is treated as the absence of verification. A workable intake procedure distinguishes full checks at first supply from reduced checks on repeat deliveries of the same device and batch, while still requiring the distributor to react to any indication that a device is not in conformity: Article 14 places the stop-and-notify duty on the distributor the moment such an indication arises, independently of whether the goods-in checklist was completed for that particular delivery.

Insight 2: The EUDAMED registration duty of distributors is decided by each Member State.

Article 27 is the provision on electronic systems for the registration of economic operators, and it allows Member States to establish local registration requirements for distributors within their territory (as interpreted in MDCG 2021-13 Rev.1). This differs from the mandatory registration of manufacturers, authorised representatives and importers under Article 28: distributor registration is an optional requirement at Member State level. A distributor operating across several Member States therefore faces a patchwork that must be checked country by country, and a compliance programme built on the assumption that distributors never register anywhere will fail in those Member States that have exercised the option.

Insight 3: Storage and transport conditions are a compliance duty, not a commercial term.

Article 14 requires distributors to store and transport devices under the conditions specified by the manufacturer. Cold-chain IVDs are especially sensitive: missing temperature-deviation records undermine the upstream performance and stability evidence, and create attribution difficulties in the vigilance and trend-reporting stage under Articles 82 and 83. The transport leg is where these failures concentrate, since distributors often subcontract logistics, so the duty extends to ensuring that subcontracted transport also follows the specified conditions and produces usable temperature records. For high-sensitivity IVDs such as reagent kits with defined storage ranges, the distributor should also define the handling of excursions: quarantining the affected stock, documenting the deviation, and consulting the manufacturer before releasing the goods, because a released shipment without a documented excursion assessment leaves the distributor exposed if the downstream performance of the device is later questioned.

Insight 4: Article 16 applies to distributors as well.

A distributor that makes devices available under its own name or trademark, changes their intended purpose, or modifies them in a way that may affect conformity is deemed to be the manufacturer (Article 16(1)). Private labelling and repackaging are the common trigger points. Repackaging enjoys a limited exception under Article 16(2)(b), but it is conditional on meeting the quality management system and the 28 days in advance notification requirements of Articles 16(3) and (4), together with the conditions that the repackaging is necessary to place the device on the market of the Member State concerned and does not adversely affect the original condition of the device.

4. Practical recommendations

1. Build a distributor intake verification checklist (CE, Declaration of Conformity, instructions for use, identification chain) and a non-conformity notification procedure.
2. Write the storage and transport conditions for temperature-controlled products into the distribution agreement and require temperature records to be provided.
3. Confirm per Member State whether the distributor needs local registration (Article 27).
4. Maintain a UDI ledger (Article 24(8)) consistent in scope with upstream and downstream records.
5. Run an Article 16 assessment before starting any private-labelling or repackaging activity, then follow the procedures of Articles 16(3) and (4).

5. Verification checklist

• □ CE mark, EU Declaration of Conformity and instructions for use verified as present
• □ Identification of the manufacturer and, where applicable, the importer and authorised representative verified as complete
• □ Storage and transport conditions written into the distribution agreement and records retained
• □ Local registration requirements for distributors per Member State confirmed (Article 27)
• □ UDI retention ledger established (Article 24(8))
• □ Article 16 assessment completed for private-labelling and repackaging requests

Legal information verified as of 2026-10-29.

GRZAN supports in vitro diagnostic manufacturers entering the EU market under Regulation (EU) 2017/746 as EU Authorised Representative (EC REP) and PRRC provider, including distributor compliance frameworks, Article 16 assessments, cold-chain documentation practices and fee budgeting. For supply-chain compliance support, contact info@grzanglobal.com.